comparemela.com

Latest Breaking News On - Christopher lieu - Page 2 : comparemela.com

Bristol Myers CAR-T therapy approved by FDA for earlier myeloma use

BioPharma

United statesRaymond jamesSean mccutcheonBristol myersDrug administrationUniversity of coloradoBristol myers squibbDive briefLegend biotechChristopher lieu

Why are so many young people getting cancer? What the data say

Clues to a modern mystery could be lurking in information collected generations ago. Clues to a modern mystery could be lurking in information collected generations ago.

United statesVanderbilt universityDana farber cancer instituteSouth koreaUnited kingdomUniversity of chicagoSouth australiaFlinders universitySouth africaCandace henleyChadwick bosemanIrit ben aharonTomotaka ugaiSonia kupferBarbara cohnBoitumelo ramasodi

Increase in colon cancer among millennials

Obesity could be a possible suspect for this worrying rise in numbers.

United statesUnited kingdomAmerican cancer societyBloomberg tribune news serviceOnset colorectal programNurse health studyUniversity of colorado cancer centerChristopher lieuColorado cancer centerNancy youYoung onset colorectal programTribune newsColon cancer

🔒 The cause of colon cancer susceptibility in millennials and Gen Z

Colon cancer has become the leading cause of cancer deaths in men under 50, while ranking second in women under 50, surpassing breast cancer.

United statesUnited kingdomColleen aldousLisa jarvisOnset colorectal programNurse health studyAmerican cancer societyUniversity of colorado cancer centerBiznews insiderProf colleen aldousChristopher lieuColorado cancerNancy youYoung onset colorectal program

FDA Panel Endorses DFMO for Kids High-Risk Neuroblastoma in Remission

Large improvement in event-free survival, but questions linger about sources of data

United statesLos angelesNicole dreznerShahab asgharzadehCharles bankheadUniversity of colorado cancer centerOncologic drugs advisory committeeChristopher lieuColorado cancer centerHospital los angelesMedpage today

vimarsana © 2020. All Rights Reserved.